Health Care Report Cards: Why Should Community Pharmacists Care?

Joint Commission on Accreditation of Healthcare Organizations (JCAHO). Primer on indicator development and application: Measuring quality in health care. Chicago: JCAHO; 1992.

Nadzam DM . Development of medication-use indicators by the Joint Commission on Accreditation of Healthcare Organizations. Am J Hosp Pharm 1991;48:1925–30.

Berwick DM . Continuous improvement as an ideal in health care. N Engl J Med 1989;320(1):53–6.

MacKinnon NJ Lipowski EE . The opinions of stakeholders in provider profiling and retrospective drug utilization review: Results from a telephone survey. Am J Health Syst Pharm 2000;57:1585–91.

Hussey PS Anderson GF Osborn R . How does the quality of care compare in five countries? Health Aff 2004;23:89–99.

The Commonwealth Fund. First report and recommendations of The Commonwealth Fund's International Working Group on Quality Indicators: A report to health ministers of Australia, Canada, New Zealand, the United Kingdom, and the United States. New York: The Commonwealth Fund; June 2004.

Canadian Institute for Health Information (CIHI). Health Indicators Conceptual Framework background paper. 2001. Available: http://secure.cihi.ca/cihiweb/en/downloads/infostand_ihisd_e_ISO_background.pdf (accessed April 7, 2005).

MacKinnon NJ Hepler CD . Preventable drug-related morbidity in older adults 1. Indicator development. J Manag Care Pharm 2002;8(5):365–71.

Robertson HA MacKinnon NJ . Development of a list of consensus-approved clinical indicators of preventable drug-related morbidity in older adults. Clin Ther 2002;24(10):1595–1613.

Organisation for Economic Co-operation and Development. OECD health care quality indicators project. 2003. Available: www.oecd.org/documentprint/0,2744,en_2649_33929_2484127_1_1_1_1,00.html (accessed April 29, 2005).

Organisation for Economic Co-operation and Development. Health spending in most OECD countries rises, with the U.S. far outstripping all others. 2004. Available: www.oecd.org/documentprint/0,2744,en_2649_33929_31938380_1_1_1_1,00.html (accessed April 15, 2005).

Organisation for Economic Co-operation and Development. List of variables in OECD health data 2004 (1st edition). Available: www.oecd.org/dataoecd/28/28/31855466.pdf (accessed April 29, 2005).

World Health Organization. The world health report 2004 — changing history. 2004. Available: www.who.int/whr/2004/en/ (accessed April 8, 2005).

Brudon P Rainhorn J-D Reich MR . Indicators for monitoring national drug policies. 2nd ed. World Health Organization. 1999. Available: www.who.int/medicines/library/par/indicators/englishindfirst.pdf (accessed April 8, 2005).

Canadian Institute for Health Information. About health indicators. Health Indicators 2004;2004(1). Available: http://secure.cihi.ca/indicators/en/pdf/About_Health_Indicators.pdf (accessed April 7, 2005).

Turnkey Management Consulting. Health system performance indicators as a tool for maximizing health gain in Canada. Where do pharmaceuticals fit? Vancouver: Turnkey Management Consulting; 2001.

MacKinnon NJ McCaffrey K . Health system performance indicators as a tool for maximizing health gain in Canada. Where do pharmaceuticals fit? Available: www.merckfrosst.ca/e/health/policy/pdf/PerformanceIndicators2004.pdf.

Health Canada. 2003 First Ministers' accord on health care renewal. 2003. Available: http://www.hc-sc.gc.ca/english/hca2003/accord.html (accessed April 25, 2005).

Rx&D — Health Outcomes Working Group. Input on performance indicators for pharmaceutical management and catastrophic coverage. Ottawa: Rx&D; 2003.

Kaplan RS Norton DP . The balanced scorecard — measures that drive performance. Harv Bus Rev 1992;70(1):71–9.

Ontario Hospital Association. Hospital Reports. 2004. Available: www.oha.com/oha/reprt5.nsf (accessed April 7, 2005).

New Brunswick Provincial Government. Reporting to New Brunswickers — the New Brunswick Health Care Report Card 2003. Available: www.gnb.ca/0051/pub/pdf/hrepcard-e.pdf (accessed April 8, 2005).

Ukens C . Disciplining pharmacists. Drug Topics 2004; 148(11):56–61.

Gebhart F . More states require reporting of drug errors. Drug Topics 2003;147(3):52.

Gebhart F . California launches pharmacy quality assurance program. Drug Topics 2002;146(6):47.

Steele DR Kelly WN . Documenting errors benefits patients, pharmacies. Drug Topics 2004;148(2):66, 71.